The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of 

Browse by Topic:

OHSU Study Validates Deep Brain Surgery While Asleep for Parkinson's Patients

New App Adjusts Brain Stimulators For Parkinson’s Patients

CurePSP 2017 Southwest Family Conference to be Held in Phoenix on March 17-18, 2017

Adamas Announces US FDA Acceptance of ADS-5102 New Drug Application for the Treatment of Levodopa-induced Dyskinesia in Patients with PD

Single Protein May Hold Secret to Treating Parkinson’s Disease

Blocking Brain Enzyme Corrects Motor Symptoms in Mice

Adjunctive Safinamide Increases On Time in Parkinson's Disease

The 21st Century Cures Act is Signed into Law

Fat-coated Microbubbles May Aid Parkinson’s Treatment by Getting Past Blood Brain Barrier

Upright Posture in Patients with Parkinson’s Disease Exacerbates Cognitive Defecits

Parkinson’s Disease May Be Traced to Gut Bacteria

Janet Reno, Former Attorney General, Dies at 78 from Complications of PD

Michigan State University and Van Andel Research Institute Collaborate on Research to Slow the Progression of PD

More Research Needed for Using Skin Biopsies to Diagnose Parkinson’s Disease

Parkinson's Disease Foundation Seeks Proposals for $2.7 Million in Parkinson’s Research Funding

Statin Use May Lead to Increased Risk for Parkinson’s Disease

Adamas Pharma Announces Submission of ADS-5102 NDA to US FDA as Dyskinesia Treatment in PD Patients

New Drug Candidate May Reduce Deficits in Parkinson’s Disease

Diabetes Drug Focus of New Clinical Trial for Parkinson's Disease

Experimental Immunotherapy May Slow Parkinson’s Disease Progression

Acorda’s CVT-301 for Parkinson’s ‘Off’ Periods Shows Promising Results in Preclinical Studies

New Device Helps Boost Movement in Parkinson's Patients

GLNT and UCB Partner to Create Ways to Better Judge Effectiveness of Parkinson’s Treatment

Acorda Launches “The Many Faces of Off” Facebook Page to Support the Parkinson’s Community

Global Kinetics Secures FDA Clearance to Market Upgraded Wearable for PD Patients

Nest Planning Board: Coordinating Center to Prioritize Cooperative Projects

Cynapsus Therapeutics Parkinson’s Disease Candidate Gets FDA Fast Track Designation

New Test May Help Detect Parkinson’s Disease in Early Stages of Life

NeuroDerm Initiates Patient Enrollment in a Phase III Trial of ND0612L for the Treatment of PD

Manufacturing Dopamine in the Brain with Gene Therapy

Simple Eye Test May Detect Parkinson’s Disease

Leukemia Drug Proven Effective Against Parkinson’s Disease

Researchers Examine How Parkinson’s Disease Alters Brain Activity Over Time

Cynapsus Announces Publication of Data for the Treatment of OFF Episodes in Patients with PD

Parkinson’s: Mutant Enzyme, a-Synuclein Interaction May Be Preventable 

National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) Complete Merger to Form the Parkinson's Foundation

Study Shows Cancer Drug Raises Dopamine Levels in Parkinson’s Patients

Parkinson's Disease Biomarker Found in Patient Urine Samples

Johns Hopkins Researchers Reveal Novel Protein and Involvement in Parkinson’s Disease

Scientists Offer New View on Origins of Parkinson's Disease

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinson’s Disease and Movement Disorders

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinson’s Disease

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinson’s to be Highlighted at International Conference

MS Drug Could Prove Effective Parkinson's Treatment

New Gene Shown to Cause Parkinson's Disease

Senior Helpers Introduces First Ever In-Home Parkinson's Disease Care Program

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

U.S. Approves First drug for Psychosis Linked to Parkinson's Disease

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment

Blood Test to Detect Parkinson's Disease Could Lead to Earlier Treatment

Common Gene Variation May Predict Parkinson’s Severity and Progression

Cynapsus Therapeutics’ APL-130277 Phase III Study Focus of Presentation

Acorda Therapeutics’ CVT-301 Data Will Be Featured at American Academy of Neurology

Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care

The Parkinson Alliance (Responsible for the Parkinson’s Unity Walk, Team Parkinson, and Joins Unified Parkinson’s Advocacy Council

Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s Action Network Announce Plans for Integration

U.S. WorldMeds and Zambon Partner to Bring Newron Pharmaceuticals’ Parkinson’s Disease Treatment Xadago to the U.S.

Parkinson’s Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa

Titan Pharmaceuticals Receives Feedback from FDA on Ropinirole Implant Development Program for PD

New Gene Therapy Clinical Trial

Respiratory Drug Focus of New Clinical Trial for Parkinson’s Disease

Neurolixis Announces Publications Demonstrating Effects of NLX-112 in Parkinson's Disease Models

Mitochondrial DNA Levels in the Blood Help to Detect Onset of Parkinson’s Disease

Researchers Identify Biomarker for Early Cognitive Decline in Parkinson's Disease Patients

APDA Establishes Research Fund in Memory of Joel Gerstel

Study Determines Saliva Gland Test Can Spot Early Parkinson's Disease

Dementia Drug May Improve Gait in Parkinson's Patients

Dementia Drug May Improve Gait in Parkinson's Patients

New Jersey Health Foundation/The Nicholson Foundation Award $50,000 to Advance Research to Slow Brain Degeneration in Parkinson's Disease

Acorda Therapeutics to Acquire Biotie Therapies

Pioneering Neuroprotective Results Achieved in Parkinson's Disease Preclinical Studies

Researchers Develop Techniques to Bypass Blood-Brain Barrier and Deliver Drugs to the Brain

NeuroDerm Announces Streamlined U.S. Development Plan on ND0612H and ND0612L for the Treatment of PD

Biogen Enters Collaboration with the Parkinson’s Institute and Clinical Center

LSVT LOUD® Symposium for People Living With Parkinson’s Disease Scheduled for 12.11.15 in New York City

INTREPID Clinical Trial for DBS Continues Recruitment

Rock Steady Boxing: Fighting Back Against Parkinson’s in the Ring

Podcast Focusing on Cultivating Patience for Well Being in Parkinson's Disease

The Parkinson Alliance Survey Reports a Relationship Between Patience and Well-Being in Parkinson’s Disease

Completion of Clinical Trial for PRX-002 Developed by Prothena Corporation

Data from Trial in Advanced PD Patients Using Levodopa-Carbidopa Intestinal Gel

Implanted Stem Cells Reduced Symptoms of PD during Experiment

Pharma Two B Completes Enrollment in Phase IIb Study of P2B001 for PD

Skin Test May Aid in Diagnosis of Parkinson’s and Alzheimer’s

Biotie Provides Update on Tozadenant

Eltoprazine Could Tackle Dyskinesia Side Effect in Parkinson’s Disease

First Discovery of a Physical Predictor of Freezing in PD

Recent Clinical Study Offers Hope for Potential Parkinson’s Disease Therapies

Breath Test for Parkinson's Disease

Creatine Has No Effect on Progression of Parkinson's Disease

Blood Test Aims to Detect Parkinson's in Early Stages

Neurologists Find Movement Tracking Device Helps Assess Severity of PD

Researchers Identify Two mRNA Biomarkers for Parkinson's Disease

Drinking Beer Slows Down Parkinson's and Alzheimer's Disease

Tipping point of Parkinson's Disease discovered by Cambridge University Researchers

Blue Light Potential for Parkinson's Treatment

Parkinson’s Study Dims Ambitions for Gene Flaw Carried by Brin

The LSVT LOUD Training and Certification Workshop

LTI Receives Funding for Research Aimed at Delaying or Preventing Parkinson’s Disease

How To Shake the Shakes:  A Patient, Family, and Physician Seminar on Tremor and Parkinson's

Portable Device Could Be Used to Treat Parkinson’s Disease

Scientists Find Drug Candidates Can Block Cell Death Pathway Associated with PD

UCB and Neuropore Enter Into World-Wide Collaboration and Agreement

Researchers Discover Molecule that May Lessen Severity of Parkinson's Disease

23andMe and Genentech to Analyze Genomic Data for Parkinson's Disease

FDA Approves Rytary, Extended-Release Oral Treatment for PD

PD Patients Improve Strength, Quality Of Life With Exercise

Safinamide New Drug Application Re-submitted to the FDA

Treating Parkinson’s Disease with Targeted Therapeutic Vaccines

EU Recommends Parkinson’s Drug for Approval

Canadian Researchers Studying New Target for Parkinson’s Treatment

U.S. FDA Approves AbbVie’s DUOPA™ Enteral Suspension for Treatment of Advanced PD

Study Establishes Connection Between Gut Microbiota and Parkinson's Disease

NYU Langone Parkinson’s and Movement Disorders Center Launches Interdisciplinary Medical Home Visit Program

The Parkinson Alliance Participated in Podcast Featuring Top 2014 DBS Surveys

DBS4PD Speech Survey Report Published in Parkinsonism & Related Disorders

Adamas Pharmaceuticals Expands Clinical Trial for Treatment of Levodopa-induced Dyskinesia

NeuroDerm Presents Results of Continuous Subcutaneous Administration of Levodopa/Carbidopa Trials

Legislation Proposed to Provide Training for In-home Family Caregivers

University of Virginia Researching Use of Ultrasound to Treat PD

Clinical Trial to Evaluate Repurposing Existing Medication as PD Treatment

UCLA Researchers Find Drug Used for Another Disease Slows PD Progression

University of Michigan to Study Risk of Falls in PD

Autonomic Dysfunction in Parkinson’s Disease With and Without Deep Brain Stimulation

Podcast Focusing on Top 2014 DBS Surveys Scheduled for 11.7.14

I Am Ali, New Documentary About Muhammad Ali

Free Seminar Focusing on a Treatment for Parkinson`s Disease and Essential Tremor

Cedars-Sinai Receives NIH Grant to Study Motor Neuron Disorders

Device to Help People with PD Communicate Better Now Available

Wearable Tracker for Parkinson's Disease Receives FDA Approval

Acorda to Buy Civitas Therapeutics, Developer of Parkinson's Treatment

MedGenesis Enters Into Agreement with Pfizer for Treatments for PD

CE Mark for Boston Scientific’s Vercise™ DBS System for Treating Tremors

Google Acquires Manufacturer of Specialized Spoon for Use with PD , (September 16, 2014) - Google recently acquired Lift Labs, a small firm that manufactures a special spoon to make it easier for individuals with Parkinson’s disease to eat. The spoon by

Advances in Parkinson's Disease Treatment Earns Prestigious Prize

Gene to Fight Parkinson's Disease Discovered by UCLA Researchers

Microsoft Uses Software to Help Those Living with Parkinson’s Disease

Mark Morris Dance Group One of Google's Giving Through Glass Challenge Winners

Teva Recalls Generic Parkinson's Drug

Medtronic Buys Sapiens SBS

Intel Explores Wearable Devices for Parkinson's Disease

A New Drug XPro1595 May Slow Progression of Parkinson’s Disease

  Study of First Parkinson's Disease Vaccine Shows Encouraging Results

NeuroDerm Announces Eligibility for European Union Centralized Procedure for ND0612H

"How to Live Well with Parkinson's Disease" Seminar

The Michael J. Fox Foundation for Parkinson’s Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study

A New Study Reveals Why Coffee Protects Some Against Developing Parkinson's Disease

The Michael J. Fox Foundation for Parkinson's Research Awards Second Grant to Cynapsus Therapeutics

MRI Brain Scans Detect People with Early Parkinson's Disease

Mitochondria-Targeted Therapeutic Discovery Research Project Underway

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUD™

First Ever World Parkinson Coalition Scientific Update

Medicare & Parkinson’s Disease: Therapy Caps and the Exceptions Process

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson`s Disease and Movement Disorders

National Parkinson Foundation Study Finds U.S. Neurologist Care Saves 4,600 Lives of People with Parkinson`s Disease Each Year

 University of Alabama Study Finds LRRK2 May Be Key to Combating Parkinson`s Disease

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease

Largest Ever Trial in Parkinson`s Disease Shows That For Long Term Treatment Levodopa is Better Than Newer Drugs

UCLA Researchers Identify New Gene Involved in Parkinson's Disease

FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)

Teva`s Parkinson Drug Now Marketed in Japan

Rice University Researcher Rebooting Deep Brain Stimulation

Specialized Care Urged for Treating Parkinson's Disease

CEO of The Parkinson Alliance Appointed to Brookings’ National Medical Device Postmarket Surveillance System Planning Board

Exenatide Has Potential as a Disease Modifying Agent in Parkinson`s Disease

Civitas Announces Positive Results from Phase II Inhaled Levodopa Trial

The Parkinson Alliance Reports Findings Pertaining to Sleep in Parkinson’s

Brain Imaging Tracer for Parkinson`s Disease

Boston Scientific Corporation Enrolls the First Patient in a New Registry to Evaluate the Value of the Vercise™ Deep Brain Stimulation (DBS) System

Impax Pharmaceuticals Resubmits New Drug Application for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066)

Completion of a Study on Retinal Pathology in an Animal Model of Parkinson`s Disease

FDA Approves Vanderbilt Trial for Parkinson’s Treatment

Google Glasses Could Help Parkinson’s Sufferers

Parkinson`s Disease and Pesticides: What's the Connection?

AbbVie Announces Availability of New Advanced Parkinson`s Treatment in Canada

MRI Interventions' Clearpoint System Now Utilized at Emory University in Atlanta

Potential Parkinson's Therapy Secures $23 Million for Testing from NIH after Foundation Funding

"Electronic Skin": New Hope for Parkinson’s Patients

Parkinson`s Support Group at Capital Health Medical Center

Parkinson`s Organizations Applaud Efforts to Bring More Drugs to Market

Advances in Treating Parkinson’s, Essential Tremor, Dystonia, Tourette’s, and Obsessive-Compulsive Disorder

The Communication Connection: The Art & Science of Staying in Touch while Living Well with Parkinson’s

New Research Offers Explanation About Why Deep Brain Stimulation Works

UCLA Researchers Link Common Pesticides to Parkinson’s Disease

NeuroDerm Announces Enrollment in a Second Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease

New survey available on "Autonomic Symptoms in Parkinson's Disease"

Study Evaluating Additional Indications for Teva’s Azilect

Berg And The Parkinson's Institute And Clinical Center Announce Key Clinical Study Focused On Game-changing Innovations In Parkinson's Disease Biomarker Discovery

FDA Approves Chelsea Therapeutics’ Northera for Treatment of Neurogenic Orthostatic Hypotension

National Parkinson Foundation Partners with SBR Health Provide Increased Access to Expert Parkinson's Disease Care

Ruby Foundation to Merge with Davis Phinney Foundation

Device to Help Prevent Falls Invented in Australia

Research Identifies Enzyme that Blocks Paths to Parkinson's Disease

Research Identifies Enzyme that Blocks Paths to Parkinson's Disease

New Potential Cell Therapy for Parkinson’s

PatientsLikeMe and Sage Bionetworks Launch Open Science Study for People with Parkinson's Disease

For Workers with Parkinson's, It's a Tough Job

Crossing the Lines Between Parkinson's and Alzheimer's

Researchers ID More Pesticides Linked to Parkinson's, Gene that Increases Risk

Hot Topics in Movement Disorders: Treatment Options for Parkinson’s Disease, Essential Tremor, and Dystonia

Amarantus In-licenses Levadopa-induced Dyskinesia Phase 2b-ready Eltoprazine from PGI Drug Discovery

Novel Gene Therapy for Parkinson’s Disease Clears Hurdle

Disparities Among Which Parkinson’s Patients Receive Deep Brain Stimulation

Asleep During Brain Surgery: A Comfortable Alternative for Patients with Parkinson's Disease

Gene Found That Protects Against Neurodegenerative Diseases

Parkinson's Research Study Shows Inosine Compound Raises Urate Levels

February 7th Achieve Daily Victories Seminar Focusing on a Treatment for Parkinson's Disease and Essential Tremor

Researchers Discover That an Important Clue to Diagnosing Parkinson’s Disease May Lie Just Beneath the Skin

“Smart glasses” to Improve Gait of Parkinson's Patients

Neurologist at Emory Awarded $3 Million Life Sciences Breakthrough Award

Medtronic Recently Received FDA Approval of Updated Labeling for DBS for Parkinson’s Disease

Ohio State Study Shows Exercise Improves Depression in Parkinson's Patients

Stanford Researchers Record Data from Brain of Ambulatory Parkinson's Patient

Falls and Fear of Falling in Parkinson’s Disease With and Without Deep Brain Stimulation

UCLA and Emory Researchers Find a Chemical Signature for 'Fast' Form of Parkinson’s

Genetic Mutation Increases Risk of Parkinson's Disease from Pesticides

Gene-Silencing Study Finds New Targets for Parkinson's Disease

NINDS Sponsors Parkinson’s Meeting to Identify Challenges and Define Research Priorities

MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans with Parkinson's Disease

New Parkinson's Disease Genes Discovered by the Parkinson's Institute and Clinical Center and Population Diagnostics, Inc.

US WorldMeds Launches Final Phase III Trial to Study Myobloc Injections to Treat Drooling

The Parkinson Alliance to Attend Victory Summit Symposium

Neurosurgeon Provides “Asleep” Option for Patients Undergoing DBS Surgery

New Survey Available on “Sleep in Parkinson’s Disease: A Comparison Between Those With and Without Deep Brain Stimulation”

MRI Interventions' ClearPoint System Enables Precise Delivery of Promising Investigational Gene Therapy in Parkinson's Disease Phase I Clinical Trial

New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy

Listen to The Parkinson Alliance Discussion Regarding Resilience and Parkinson’s on Voice Aerobics BlogTalkRadio

Upcoming Presentation on Speech and Parkinson’s at the 2013 ASHA Convention

Real-time adaptive brain control: Combining a BCI with DBS to treat Parkinson’s.

Video Series on Parkinson’s Released by Veterans Health Administration

New Surgical Technique for Deep Brain Stimulation Proves Accurate and Safe

Parkinson’s book geared toward helping families across the globe.

 Achieve Daily Victories Seminar Focusing on Treatment for Parkinson’s Disease

The Parkinson Alliance Presents Speech Data to Medtronic Corporate Leadership

Get Your Copy of "Communication and Swallowing Disorders in Parkinson Disease"

Neuropsychiatric Symptoms in Parkinson's Disease

Does Deep Brain Stimulation (DBS) prevent progression of Parkinson’s Disease (PD) or it only masks some of the symptoms of PD? , Oleg Kopyov MD PhD Principal Investigator (St John's Oxnard), Brian Ross MD PhD Principal Investigator (HMRI), Alexander Lin MS Neuroscientist (HMRI and RSRI), Thao T. Tran BS MR spectroscopist (HMRI and RSRI), William Theurer MD Neuroradiologist (St J

Neural Interfaces Workshop, August 2006 , Dr. Jeffrey Wertheimer

Jeffrey Wertheimer's presentation at the Neural Interface Conference, 2006 , Jeffrey Wertheimer

Speech by Margaret Tuchman given at Neural Interfaces DBS Patient Panel - August 21, 2006 Bethesda, MD , Margaret Tuchman

Speech by Dr. David Heydrick given at Neural Interfaces DBS Patient Panel - August 21, 2006 Bethesda, MD , Dr. David Heydrick

Updates on PD from the latest Udall Center: A conference at Northwestern Memorial Hospital , The Parkinson Alliance/DBS-STN Research Team

A Review of the Neural Interfaces Workshop: National Institutes of Health and the National Institute of Neurological Disorders and Stroke , The Parkinson Alliance/DBS-STN Research Team

The 9th International Congress of Parkinson's Disease and Movement Disorders - Part One , The Parkinson Alliance/DBS-STN Research Team

The 9th International Congress of Parkinson's Disease and Movement Disorders - Part Two: Sleep Disorders in Parkinson's Disease , The Parkinson Alliance/DBS-STN Research Team

The 9th International Congress of Parkinson's Disease and Movement Disorders - Part Three: Balance and Gait in Parkinson's Disease , The Parkinson Alliance/DBS-STN Research Team

The 9th International Congress of Parkinson's Disease and Movement Disorders - Part Four: Programming following Deep Brain Stimulation , The Parkinson Alliance/DBS-STN Research Team

What is Comorbity? , The staff

New Study Shows 42% of Parkinson's Patients Who Suffer From Debilitating Off Episodes Claim They Strike Without Warning 1(p9) , Pharmalive -

The Future of Neuromodulation , The Parkinson Alliance/DBS-STN Research Team

Neural Interfaces Workshop , The Parkinson Alliance/DBS-STN Research Team

WE MOVE annouces: The DBS-STN Programmers Discussion Forum ,

DBS-STN and Sleep: A Review of the Literature , The Parkinson Alliance/DBS-STN Research Team

DBS-STN and Speech: A Review of the Literature , The Parkinson Alliance/DBS-STN Research Team

Be Prepared For Medical Emergencies , By Stuart A. Arnheim

Quality of Life in DBS-STN: Introduction and Review , The Parkinson Alliance/DBS-STN Research Team

Deep Brain Stimulation and How DBS-STN Works , DBS-STN staff

The Zen of DBS Programming , By Roberta Rubin, RN, CNOR, RNFA, California Neuroscience Institute

A Conference on Depression , by Irene Richard, M.D. Assistant Professor University of Rochester Medical Center, Rochester, NY

Quality of Life - Depression in Parkinson's Patients